Literature DB >> 16779320

Approach for analysis of order check overrides in a computerized practitioner order entry system.

Ching-Ping Lin1, W Paul Nichol, Patty Hoey, Terry L Roth, Curtis Anderson, John H Gennari, Thomas H Payne.   

Abstract

While it has been established that electronic order entry systems can prevent transcription errors and check orders for severe drug allergies and interactions, continuous monitoring of the effectiveness of order checks is important. The goal of this study is to examine the rate at which high severity order checks generated in the electronic medical record at VA Puget Sound are overridden by clinicians. We compare our results to those of a previous study that found high override rates for Critical Drug Inter-action and Allergy-Drug Interaction order check categories. We are interested in determining whether system changes addressing these high rates have been successful in reducing the overall override rate in these categories. Because the method used previously to extract orders is no longer available, the first step in our study was to develop a new procedure to gather order entry data. This procedure is the subject of our report.

Entities:  

Mesh:

Year:  2005        PMID: 16779320      PMCID: PMC1560465     

Source DB:  PubMed          Journal:  AMIA Annu Symp Proc        ISSN: 1559-4076


  2 in total

1.  Characteristics and override rates of order checks in a practitioner order entry system.

Authors:  Thomas H Payne; W Paul Nichol; Patty Hoey; James Savarino
Journal:  Proc AMIA Symp       Date:  2002

2.  Effects of computer-based clinical decision support systems on physician performance and patient outcomes: a systematic review.

Authors:  D L Hunt; R B Haynes; S E Hanna; K Smith
Journal:  JAMA       Date:  1998-10-21       Impact factor: 56.272

  2 in total
  1 in total

1.  Provider and pharmacist responses to warfarin drug-drug interaction alerts: a study of healthcare downstream of CPOE alerts.

Authors:  Allison M Miller; Maureen S Boro; Nancy E Korman; J Ben Davoren
Journal:  J Am Med Inform Assoc       Date:  2011-10-28       Impact factor: 4.497

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.